Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daren Wang

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology|May 17, 2024
Salivary gland carcinosarcoma ex pleomorphic adenoma: a case report with molecular characterizationSehrish Javaid, Daren Wang, Benjamin J Kelly, et al.
Pharmaceutical Research|January 12, 2023
Mucopenetrating Janus Nanoparticles For Field-Coverage Oral Cancer ChemopreventionNahal Habibi, Caroline Bissonnette, Ping Pei, et al.
Pharmaceutics|November 27, 2025
Engineered Fenretinide- and Tocilizumab-Releasing Janus Nanoparticles for Site-Directed Immunochemoprevention of Squamous Cell Carcinoma of the LungDaren Wang, Albert Chang, Fortune Shea, et al.
Plos One|July 17, 2014
Stiffening-induced high pulsatility flow activates endothelial inflammation via a TLR2/NF-κB pathwayYan Tan, Pi-Ou Tseng, Daren Wang, et al.
Sensors (Basel, Switzerland)|April 27, 2024
Development of Multimodal Fusion Technology for Tomato Maturity AssessmentYang Liu, Chaojie Wei, Seung-Chul Yoon, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 6, 2013
Engineering a lysosomal enzyme with a derivative of receptor-binding domain of apoE enables delivery across the blood-brain barrierDaren Wang, Salim S El-Amouri, Mei Dai, et al.
Molecular Cancer Therapeutics|September 14, 2019
Fenretinide, Tocilizumab, and Reparixin Provide Multifaceted Disruption of Oral Squamous Cell Carcinoma Stem Cell Properties: Implications for Tertiary ChemopreventionSusan R Mallery, Daren Wang, Brian Santiago, et al.
Oral Oncology|December 3, 2011
Methylation of microRNA-9 is a specific and sensitive biomarker for oral and oropharyngeal squamous cell carcinomasJacob Minor, Xiaotian Wang, Fang Zhang, et al.
Cancer Prevention Research (Philadelphia, Pa.)|October 30, 2016
Benefits of Multifaceted Chemopreventives in the Suppression of the Oral Squamous Cell Carcinoma (OSCC) Tumorigenic PhenotypeSusan R Mallery, Daren Wang, Brian Santiago, et al.
Carcinogenesis|August 16, 2022
Fenretinide combines perturbation of signaling kinases, cell-extracellular matrix interactions and matrix metalloproteinase activation to inhibit invasion in oral squamous cell carcinoma cellsDaren Wang, Ping Pei, Fortune F Shea, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology|May 17, 2024
Salivary gland carcinosarcoma ex pleomorphic adenoma: a case report with molecular characterizationSehrish Javaid, Daren Wang, Benjamin J Kelly, et al.
Pharmaceutical Research|January 12, 2023
Mucopenetrating Janus Nanoparticles For Field-Coverage Oral Cancer ChemopreventionNahal Habibi, Caroline Bissonnette, Ping Pei, et al.
Pharmaceutics|November 27, 2025
Engineered Fenretinide- and Tocilizumab-Releasing Janus Nanoparticles for Site-Directed Immunochemoprevention of Squamous Cell Carcinoma of the LungDaren Wang, Albert Chang, Fortune Shea, et al.
Plos One|July 17, 2014
Stiffening-induced high pulsatility flow activates endothelial inflammation via a TLR2/NF-κB pathwayYan Tan, Pi-Ou Tseng, Daren Wang, et al.
Sensors (Basel, Switzerland)|April 27, 2024
Development of Multimodal Fusion Technology for Tomato Maturity AssessmentYang Liu, Chaojie Wei, Seung-Chul Yoon, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 6, 2013
Engineering a lysosomal enzyme with a derivative of receptor-binding domain of apoE enables delivery across the blood-brain barrierDaren Wang, Salim S El-Amouri, Mei Dai, et al.
Molecular Cancer Therapeutics|September 14, 2019
Fenretinide, Tocilizumab, and Reparixin Provide Multifaceted Disruption of Oral Squamous Cell Carcinoma Stem Cell Properties: Implications for Tertiary ChemopreventionSusan R Mallery, Daren Wang, Brian Santiago, et al.
Oral Oncology|December 3, 2011
Methylation of microRNA-9 is a specific and sensitive biomarker for oral and oropharyngeal squamous cell carcinomasJacob Minor, Xiaotian Wang, Fang Zhang, et al.
Cancer Prevention Research (Philadelphia, Pa.)|October 30, 2016
Benefits of Multifaceted Chemopreventives in the Suppression of the Oral Squamous Cell Carcinoma (OSCC) Tumorigenic PhenotypeSusan R Mallery, Daren Wang, Brian Santiago, et al.
Carcinogenesis|August 16, 2022
Fenretinide combines perturbation of signaling kinases, cell-extracellular matrix interactions and matrix metalloproteinase activation to inhibit invasion in oral squamous cell carcinoma cellsDaren Wang, Ping Pei, Fortune F Shea, et al.
Pageof 3